49
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Concurrent Mediastinal B Cell Lymphoma and Chronic Myeloid Leukemia with an Unusually Favorable Response to Chemotherapy

, , , , &
Pages 535-538 | Published online: 01 Jul 2009

  • Biemaux, C., Loos, M., Sels, A., Huez, G. and Stryckmans, P. (1995) "Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals", Blood 86(8), 3118-3122.
  • Bose, S., Deininger, M., Gora-Tybor, J., Goldman, J.M. and MeIo, I.V. (1998) "The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease", Blood 92(9), 3362-3367.
  • Au, W.Y., Lie, A.K., Ma, S.K., Wan, T.S., Liang, R., Leung, Y.H. and Kwong, Y.L. (2001) "Philadelphia (Ph) chromosome-positive chronic myeloid leukaemia relapsing as Ph-negative leukaemia after allogeneic bone marrow transplantation", Br. J. Haematol. 114(2), 365-368.
  • Reeves, I.E., Robbins, B.A., Pankey, L.R., Elias, A.L. and Anderson, W.F. (1995) "The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report", Cancer 75(8), 2089-2092.
  • Kwong, Y.L. and Cheng, G. (1993) "Clonal nature of chronic neutrophilic leukemia", Blood 82 (3), 1035-1036.
  • Au, W.Y, Chan, A.C. and Kwong, Y.L. (1999) "Isolated lymph node T lymphoblastic transformation of chronic myeloid leukemia during interferon treatment", Am. J. Hematol. 62(4), 256-258.
  • Acar, H., Ecirli, S., Gundogan, E, Bulay, O. and Acar, A. (1999) "Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis", Cancer Genet. Cytogenet. 108(2), 171-174.
  • Montefusco, E., Lo Coco, E, Burgio, V.L., Rondinelli, B., Di Giorgio, G., Mancini, M., Diverio, D., Andrioni, A., Avvisati, G. and Alimena, G. (1993) "Occurrence of a Ki-I-positive anaplastic large-cell lymphoma in a patient with Ph-positive chronic myelogenous leukemia successfully treated by alpha-interferon", Leukemia 7(11), 1896-1899.
  • Ichinohasama, R., Miura, I., Takahashi, N., Sugawara, T., Tamate, E., Endoh, K., Naganuma, H., DeCoteau, I.E., Griffin, I.D., Kadin, M.E. and Ooya, K. (2000) "Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature", Leukemia 14(1), 169-182.
  • Vemeris, M.R., Tuel, L. and Seibel, N.L. (1995) "Pediatric HIV infection and chronic myelogenous leukemia", Pediatr. AIDS HIV Infect. 6(5), 292-294.
  • Vey, N., Camerlo, J., Xerri, L., Petit, N., Dermeche, S. and Maraninchi, D. (2001) "Simultaneous occurrence of kaposi's sarcoma and chronic myelogenous leukemia", Leak. Lymphoma 41(3-4), 425-428.
  • Johnson, R.J., Owen, R.G., Child, J.A., Morgan, G.J., Barnard, D.L., Dickinson, H., Ricketts, S., Rawston, A., Evans, P., Woodhead, V, Major, K., Robinson, F. and Smith, G.M. (1996) "Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim)", Br. J. Haematol. 93(4), 863-868.
  • Mandigers, C.M., Mensink, E.J., Geurts van Kessel, A., van der Plas, D.C., Haanen, C., Hagemeyer, A. and de Witte, T. (1996) "A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone", Ann. Hematol. 72(6), 371-373.
  • Jankovic, G.M., Bogdanovic, A.D., Colovic, M.D., Novak, A.V., Andolina, M. and Anagnostopoulos, A. (1996) "Implications of prominent cytologie dysplasia persisting in the marrow of a patient with CML even after the spontaneous disappearance of the Philadelphia chromosome", Am. J. Hematol. 52(3), 234-235.
  • Fegan, C, Morgan, G. and Whittaker, I.A. (1989) "Spontaneous remission in a patient with chronic myeloid leukaemia", Br. J. Haematol. 72(4), 594-595.
  • Cagirgan, S., Sencan, M., Tombuloglu, M., Ozdemir, E., Hekimgil, M. and Buyukkececi, F. (1998) "Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia", Leak. Lymphoma 29(3-4), 423-425.
  • Selleri, L., Emilia, G., Temperani, P., Grassilli, E., Zucchini, P., Tagliafico, E., Bonati, A., Venezia, L., Ferarri, S. and Torelli, U. (1989) "Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival", Leukemia 3(7), 538-542.
  • Prischl, F.C., Haas, O.A., Lion, T., Eyb, R. and Schwarzmeier, I.D. (1989) "Duration of first remission as an indicator of long-term survival in chronic myelogenous leukaemia", Br. J. Haematol. 71(3), 337-342.
  • Aviram, A., Blickstein, D., Stark, P., Luboshitz, I., Bairey, O., Prokocimer, M. and Shaklai, M. (1999) "Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients", Leak. Lymphoma 33(1-2), 77-82.
  • Blickstein, D., Aviram, A., Luboshitz, I., Prokocimer, M., Stark, P., Bairey, O., Sulkes, J. and Shaklai, M. (1997) "BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation", Blood 90(7), 2768-2771.
  • Sokal, I.E., Cox, E.B., Baccarani, M., Tura, S., Gomez, G.A., Robertson, I.E., Tso, C.Y., Braun, T.J., Clarkson, B.D. and Cervantes, F. (1984) "Prognostic discrimination in 'good-risk' chronic granulocytic leukemia", Blood 63(4), 789-799.
  • Hasford, I., Pfirrmann, M., Hehlmann, R., Allan, N.C., Baccarani, M., Kluin-Nelemans, I.C., Alimena, G., Steegmann, I.L. and Ansari, H. (1998) "A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group", J. Natl Cancer last. 90(11), 850-858.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.